Skip to main content

Chloramphenicol Sodium Succinate Injection, an antibiotic, expands Fresenius Kabi's anti-infective portfolio.

May 10

May 10, 2016
Bad Homburg, Germany

Quarterly Financial Report Q1 2016 (IFRS)

May 06

May 06, 2016
Bad Homburg, Germany

Quarterly Financial Report Q1 2016 (US-GAAP)

Linezolid injection further expands the Fresenius Kabi anti-infective portfolio. It is available in the company's proprietary Freeflex® bag.

University Hospital of Munich has joined the growing “Wir für Gesundheit” hospital network, becoming the first university clinic to accept PlusCard. Through its supplementary company health insurance, PlusCard offers employers coverage options that provide employees with different levels of service and comfort. “Wir für Gesundheit” was formed by hospital operators Asklepios, Fresenius Helios and Rhön, and has more than 120 partner hospitals in Germany committed to quality standards far higher than those required by law.
Vamed is realizing the new main building of University Hospital Schleswig-Holstein in Kiel, Germany as part of a public-private partnership. The company will also be responsible for the long-term technical management of the building, which will house more than 600 beds and 22 operating rooms. The work is part of a comprehensive construction and modernization project at the hospital. Completion is scheduled for 2019.
April 13

April 13, 2016
Baden-Baden, Germany

Bankhaus Lampe Deutschlandkonferenz

Amikacin Sulfate Injection, an antibiotic, expands Fresenius Kabi's anti-infective portfolio.

After nine months of construction, a new central sterilization unit has been opened at HELIOS Hospital Dr. Horst Schmidt Kliniken in Wiesbaden, Germany. Up to 75,000 medical instruments will be cleaned and sterilized annually in the unit, for use in five HELIOS hospitals. The total investment was about €4 million.

Subscribe to